The sell to buy ratio for Livongo Health, Inc. (NASDAQ:LVGO) over the past 12 months was at 0, pointing to bullish sentiments about the stock among corporate executives and directors. LVGO recorded 2 sales transactions on the open market over the last 3 months with a sale of around 63,351 shares. On the other hand, purchases amounted to 73,533,388 shares in that period. Looking at a longer time frame, the 52 week selling total stands at 63,351 shares when buyers snapped up 73,533,388 shares. The total signifies nearly a 0-to-1 sell/buy ratio.
On October 08, 2019, Livongo Health, Inc. (NASDAQ:LVGO) shares lost -6.83% or -1.4 points to close at $19.1 with a heavy trading volume of 1.685 million shares. It opened the trading session at $20.61, the shares rose to $20.75 and dropped to $18.89, the range by which the price of stock traded the whole day. The company now has a market cap of $1.84 billion and currently has 96.3 million outstanding shares. Livongo Health, Inc. (LVGO) stock has plunged -18.62 percent of market value in 21 trading days.
LVGO stock’s trailing 3-year beta is 0, meaning there will be a lower rate of return, although posing a lower risk. The part of a firm’s profit given to each outstanding share of regular stock was -$0.58 share in the trailing 52 weeks. The stock’s value fallen -49.87 percent year to date (YTD) compared to a decline of 0 percent in 52 week’s period. The firm’s shares are still trading -58.19 percent below its 1-year high of $45.68 and 26.32 percent up from 52-week low of $15.12. The average consensus ranking on the company is 1.7, on a ranging where 5 is equal to a consensus sell rating. In other words, the mean analyst recommendations are ranking this stock as a buy.
Livongo Health, Inc. (LVGO) is most likely going to rise 130.37 percent in the coming 12 months, as per price target approximations compiled by finviz. Nevertheless, they have set the price target at a $50-month high price target. This represents a whopping 161.78 percent increase from the current trading of shares. The 52-week median price target given by the analysts is $42.5, which means a return possibility of 122.51 percent in comparison with the closing price of the stock of $19.1 on October 08. The lowest price set for the stock is $30 — just above 57.07 percent from LVGO share price now.
Past records have indicated that shares in Livongo Health, Inc. declined on 1 different earnings reaction days and we have yet to see whether this trend will play out and remain in place when the company reports upcoming earnings.
Let’s take a glimpse at some insider activity at Livongo Health, Inc. (NASDAQ:LVGO) and observe the pattern. The earliest insider trade happened on 07/29/2019. General Catalyst Group Managem gathered a total of 2.68 million shares of the firm at average share price of $28. The total amount for the purchase was set at $75 million. On completing this exchange, the 10% Owner account balance was 22.78 million shares. The stock lost -31.79 percent from that insider purchase. On 07/29/2019, GC Venture LH Manager, LLC, 10% Owner, did a purchase of 2.68 million shares at a price of $28 per share. This increased 75 million shares to the insider’s fortune and the stock experienced a -31.79 percent retreat in price since the news became public. This exchange saw 22.78 million shares get into the 10% Owner account.
On 07/29/2019, Director, 10% Owner Taneja Hemant recorded a purchase transaction valued at $75 million. The purchase at $28 a share has added 2.68 million shares into the insider’s portfolio position. Meanwhile, shares price witnessed -31.79 percent decrease since the transaction reporting date. The company insider is left with 22.78 million shares remaining in the account. Kinnevik AB (publ), who works as 10% Owner at the company, performed a purchase of 3.14 million shares in a transaction worth $87.97 million. The acquisition recorded on 07/29/2019 was priced at $28 per share. The stock price plunged -31.79 percent since the transaction. Kinnevik AB (publ) currently holds a stake of 12.65 million in LVGO stock which is worth $241.69 million after the insider buying.
The stock is lingering around the initial support level of $18.41. After this, the following support is at the zone of $17.72. Up until the time the LVGO stock hit levels beyond the current one, bulls should have no alarm. In terms of its momentum, the stock’s RSI hit 38.62 on the daily chart, and this may be a cause for comfort. In case the price goes below $17.72 level on closing basis, there may be more profit booking with the stock growing weaker. Still, getting to the $20.27 level may cause a pull-back move approaching $21.44 mark.
It is additionally sporting a 15 on the Price-to-Sales ratio, compared to the industry’s P/S average of 4.9. Livongo Health, Inc. has a 68.6% gross profit margin, with its operating margin around 0%. Alongside this, the company’s net profit margin currently stands at 0%.